LNDC
NASDAQLandec Corporation
Latest news
25 items- SECLandec Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- SECSEC Form SCHEDULE 13G filed by Landec CorporationSCHEDULE 13G - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Subject)
- 13D/GSEC Form SC 13G/A filed by Landec Corporation (Amendment)SC 13G/A - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Subject)
- INSIDERSchechter Joshua converted options into 9,554 shares, increasing direct ownership by 20% to 57,667 units (SEC Form 4)4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
- INSIDERCalloway Nathaniel converted options into 3,981 shares, increasing direct ownership by 17% to 28,069 units (SEC Form 4)4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
- INSIDERObus Nelson converted options into 9,554 shares, increasing direct ownership by 12% to 88,687 units (SEC Form 4)4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
- INSIDEREdwards Jeffrey L converted options into 9,554 shares, increasing direct ownership by 24% to 49,667 units (SEC Form 4)4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
- INSIDERDiradoorian Raymond H converted options into 9,554 shares, increasing direct ownership by 31% to 39,978 units (SEC Form 4)4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
- INSIDERHoude Lovas Katrina converted options into 9,554 shares, increasing direct ownership by 19% to 59,906 units (SEC Form 4)4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
- INSIDERBarbarosh Craig A. converted options into 9,554 shares (SEC Form 4)4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
- INSIDERMorberg John D converted options into 17,500 shares and covered exercise/tax liability with 6,283 shares, increasing direct ownership by 10% to 125,617 units (SEC Form 4)4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
- SECLandec Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- INSIDERCalloway Nathaniel converted options into 5,906 shares, increasing direct ownership by 32% to 24,088 units (SEC Form 4)4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
- SECSEC Form NT 10-Q filed by Landec CorporationNT 10-Q - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- SECLandec Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- 13D/GSEC Form SC 13D/A filed by Landec Corporation (Amendment)SC 13D/A - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Subject)
- SECLandec Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- SECLandec Corporation filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- SECLandec Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- SECSEC Form NT 10-Q filed by Landec CorporationNT 10-Q - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- SECLandec Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- SECLandec Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- 13D/GSEC Form SC 13D/A filed by Landec Corporation (Amendment)SC 13D/A - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Subject)
- SECSEC Form NT 10-K filed by Landec CorporationNT 10-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
- 13D/GSEC Form SC 13G filed by Landec CorporationSC 13G - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Subject)
LNDC FAQ
7 questionsWhat does Landec Corporation do?
Landec Corporation, together with its subsidiaries, engages in the design, development, manufacture, and sale of differentiated health and wellness products for food and biomaterials markets. It operates through Curation Foods and Lifecore segments. The Curation Foods segment engages in processing, marketing, and selling of plant-based salads, and fresh-cut and whole processed vegetables primarily under the Eat Smart brand, O branded olive oils and wine vinegars, and Yucatan and Cabo Fresh guacamole and avocado food products, as well as various private labels to retail grocery chains, club...Where does LNDC stock trade?
Landec Corporation (LNDC) is listed on NASDAQ.What sector and industry is LNDC in?
Landec Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Landec Corporation go public?
Landec Corporation (LNDC) completed its IPO in 1996.What are analysts saying about LNDC?
Landec Corporation has had 5 recent analyst actions on file. The most recent action was from Barrington Research: Outperform with a $1400.00 price target on 2022-08-11. Recent price targets range from $1300.00 to $1500.00.What companies are similar to LNDC?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare LNDC side-by-side with any of them on Quantisnow.How can I track LNDC on Quantisnow?
Quantisnow aggregates Landec Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LNDC to receive live email and push alerts on every new disclosure.